1. Matthews NH, Li W-Q, Qureshi AA, Weinstock MA, Cho E. Epidemiology of Melanoma. Cutan Melanoma Etiol Ther. 2017; Section 1, Chapter 1, p.3–22.
2. Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383:816–27.
3. Hendrix MJC, Seftor EA, Margaryan N V, Seftor REB. Heterogeneity and Plasticity of Melanoma: Challenges of Current Therapies. Cutan. Melanoma Etiol. Ther. 2017. Section 1, Chapter 4, p.57–66.
4. Testa U, Castelli G, Pelosi E. Melanoma: genetic abnormalities, tumor progression, clonal evolution and tumor initiating cells. Med Sci. 2017;5:28.
5. Jang S, Atkins MB. Which drug, and when, for patients with BRAF-mutant melanoma? Lancet Oncol. 2013;14:e60–9.